Virtual Reality (VR-GINSO) as an Complement to Intervention for Alcohol and Cannabis Use in Youth in Residential Care
VR-GINSO
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this RCT is to evaluate the effects of a virtual reality intervention on self-efficacy regarding alcohol and cannabis use among at-risk youth in various residential mental health treatment centers who have co-occurring disorders and are under the care of the association where they receive treatment. The main question it aims to answer is: • Does the VR intervention enhance the therapeutic effect of residential treatment on self-efficacy regarding alcohol and cannabis use? If there is a comparison group: Researchers will compare the intervention with the usual care (UC) that minors receive at the centers for the treatment of dual diagnosis to see if VR adds value to this treatment. Participants will be randomly assigned to each condition and will be evaluated before and after one month. In the experimental group, participants will receive a treatment session using VR software, during which they will undergo training in the following modules: The first phase is an assessment phase, during which objective measures are determined for 1) emotional recognition, 2) avoidance/approach toward related stimuli, 3) degree of compliance with social pressure, and 4) craving in the presence of the drug, exposure to cues, and/or conditioned contexts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2025
CompletedFirst Submitted
Initial submission to the registry
September 7, 2026
CompletedFirst Posted
Study publicly available on registry
September 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
September 22, 2026
September 1, 2026
11 months
September 7, 2026
September 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-Efficacy for Drug Taking measured with Drug-Taking Confidence Questionnaire (DTCQ-8)
The Drug-Taking Confidence Questionnaire (DTCQ) measures the self-efficacy of individuals regarding their ability to resist drug use.
Baseline (pre-intervention), Intervention (pre-post), Post. Up to 12 weeks
Secondary Outcomes (15)
Inventory of Callous-Unemotional Traits (ICU)
Baseline (pre-intervention)
Alcohol use measured with the Alcohol Use Disorders Identification Test (AUDIT)
Baseline (pre-intervention)
Cannabis use measured with the Cannabis Abuse Screening Test (CAST)
Baseline (pre-intervention)
Impulsive behavior measured with the UPPS-P short version
Baseline (pre-intervention)
Trait Anxiety measured with the State-Trait Anxiety Expression Inventory (STAI)
STAI-Trait: Baseline (pre-intervention). STAI-STATE: Intervention (pre-post)
- +10 more secondary outcomes
Study Arms (2)
VR intervention + Treatment as Usual
EXPERIMENTALParticipants receive treatment as usual plus one VR session. This arm includes VR to practice emotion recognition, and management of risk situations for substance use.
Treatment as usual
OTHERParticipants receive treatment as usual, no other additional intervention.
Interventions
This group will undergo a 1 individual session with a Virtual Reality program targeting emotion recognition, training on avoidance-approximation to associated stimuli, and exposure to conditioned contexts for substance use. During this session, participants will train specific abilities throug various activities. The tasks have been designed as a serious game in a Virtual Reality setting and include: emotion identification and recognition, practicing avoidance of conditioned substance use stimuli, and approximation to neutral stimuli, and exposure to conditioned situations to train regulation and management abilities for craving.
Participants in this group will receive treatment as usual provided by the facility, with no additional intervention. Treatment will be delivered ober the same period of time as in the other study group. Participants will complete one baseline assessment before the study period, and one post-intervention assessment.
Eligibility Criteria
You may qualify if:
- years old
- Admited in a residencial intervention program
- Prevision of a \>6 month stay
- Alcohol and/or cannabis use
You may not qualify if:
- Psychiatric or neurological pahology that affects cognitive functions
- Not being fluent in Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Francisco de Vitorialead
- Asociación GINSOcollaborator
Study Sites (1)
Universidad Francisco de Vitoria
Pozuelo de Alarcón, Madrid, 28223, Spain
Related Publications (1)
Roncero, D., Moreno-Fernandez, R. D., & Fernandez-Moreno, A. (2025). Effectiveness of Virtual Reality interventions for aggression, anger and impulsiveness: A multilevel meta-analysis. Aggression and Violent Behavior, 102034. https://doi.org/10.1016/j.avb.2025.102034
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- UFV
Study Record Dates
First Submitted
September 7, 2026
First Posted
September 22, 2026
Study Start
December 10, 2025
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
September 22, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly due to the highly vulnerable nature of the study population, which consists of minors (aged 13-21 years) under judicial custody. The data collected are sensitive and include mental health information, psychophysiological measures, and records of aggressive behavior within the juvenile justice system. Informed consent signed by participants and their legal guardians restricts data use to the research teams of Universidad Francisco de Vitoria and GINSO. Restricting data access ensures compliance with data protection regulations (GDPR and Spanish data protection law) and protects participants' privacy. In line with the principle of responsible openness, study results will be disseminated in aggregated and anonymized form. Any exceptional access to anonymized data would require a justified request to the Principal Investigator and evaluation under scientific, ethical, and legal criteria.